Urinary pyridinoline cross-links as biomarkers of osteogenesis imperfecta

@inproceedings{Lindert2015UrinaryPC,
  title={Urinary pyridinoline cross-links as biomarkers of osteogenesis imperfecta},
  author={Uschi Lindert and Marius E. Kraenzlin and Ana B{\'e}linda Campos-Xavier and Matthias R Baumgartner and Luisa Bonafė and Carole T. Giunta and Marianne Rohrbach},
  booktitle={Orphanet Journal of Rare Diseases},
  year={2015}
}
Osteogenesis imperfecta (OI) is a group of genetic heterogeneous connective tissue disorders characterized by increased bone fragility and susceptibility to fractures. Laboratory diagnosis relies on time-consuming and cost-intensive biochemical and molecular genetics analyses. Therefore, it is desirable to identify and establish new diagnostic markers for OI that are reliable, cost-effective and easily accessible. In our study we have identified the ratio of the urinary pyridinoline cross-links… CONTINUE READING
BETA
2
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-8 OF 8 REFERENCES

Molecular Consequences of Defective SERPINH1/HSP47 in the Dachshund Natural Model of Osteogenesis Imperfecta

U Lindert, MA Weis, +3 authors T Leeb
  • J Biol Chem
  • 2015
VIEW 1 EXCERPT

Molecular Consequences of Defective SERPINH1/HSP47 in the Dachshund Natural Model of Osteogenesis Imperfecta

U Lindert, MA Weis, +3 authors T Leeb
  • J Biol Chem
  • 2015
VIEW 1 EXCERPT

new clues to its mineralization mechanism from recessive osteogenesis imperfecta

DR Eyre, Weis MA. Bone collagen
  • Calcif Tissue Int. 2013;93(4):338–47. doi:10.1007/s00223-013-9723-9. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in Pub
  • 2015
VIEW 1 EXCERPT

new clues to its mineralization mechanism from recessive osteogenesis imperfecta

DR Eyre, Weis MA. Bone collagen
  • Calcif Tissue Int. 2013;93(4):338–47. doi:10.1007/s00223-013-9723-9. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in Pub
  • 2015
VIEW 1 EXCERPT

Similar Papers